DNA
Ginkgo Bioworks Holdings, Inc. Class A · NYSE
- Sector Health Services
- Industry Medical/Nursing Services
- Website ginkgobioworks.com
- Employees(FY) 1292
- ISIN US37611X2099
Performance
-8.87%
1W
-7.29%
1M
-35.4%
3M
-2.65%
6M
-28.82%
YTD
-73.38%
1Y
Profile
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Technical Analysis of DNA 2025-05-23
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2025-05-21 16:05
- 2025-05-19 09:45
- 2025-05-19 08:40
- 2025-03-27 06:15
- 2025-03-21 06:15
- 2025-03-13 21:35
- 2025-03-04 23:00
Ginkgo Bioworks (DNA) Upgraded to Buy: Here's Why(Yahoo Finance)
- 2025-02-25 04:00
- 2025-02-20 20:00
- 2025-02-19 19:01
- 2025-02-17 19:00
- 2025-02-06 08:01
- 2025-02-05 19:01
- 2025-01-29 12:00
- 2025-01-23 08:01
- 2025-01-22 19:01
- 2025-01-13 08:01
- 2025-01-12 19:01
- 2025-01-09 08:00
- 2025-01-08 22:38
- 2025-01-08 19:00
Page 1 of 1
previousnext
Disclaimer: The information provided here and on kavout.com is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout makes no recommendations regarding investment decisions based on this information. You are solely responsible for your investments. Please conduct your own research and consult qualified financial advisors before investing. Past performance does not guarantee future results.